OMEAT UNVEILS PLENTY'S WHITE PAPER, UNDERSCORING ITS ROBUST PERFORMANCE AS A HUMANE & AFFORDABLE FETAL BOVINE SERUM ALTERNATIVE
The Californer/10282759

THOUSAND OAKS, Calif., June 12, 2024 ~ Omeat, a leading biotechnology company, has recently released a white paper detailing the success of their product, Plenty. This nutrient-rich supplement is a humane and cost-effective replacement for Fetal Bovine Serum (FBS), commonly used in cell culture.

Plenty was first launched last year as an ethical alternative to FBS. It is derived from the plasma of living cows and is enriched with platelet lysate, which contains regenerative growth factors. These factors play a crucial role in organ regeneration and cell growth and differentiation.

One of the major advantages of Plenty is its affordability. The process of collecting enriched plasma from cows is more efficient and humane compared to the traditional method of collecting FBS, which involves the slaughter of pregnant cows and their fetuses. This not only makes Plenty more cost-effective but also adheres to high animal welfare standards.

The white paper released by Omeat includes results from independent studies conducted by prestigious research universities worldwide. These studies have shown that Plenty's performance is comparable to or even surpasses that of FBS in supporting cell growth in 15 different cell lines. This validates Plenty's efficacy and reliability as a cell culture supplement.

More on The Californer

• San Francisco Mobile Notary Streamlines Services with Cutting-Edge eJournal from Jurat Inc
• FlixxxCity.com Offers $100,000 Adult Film Contract to Luigi Mangione
• Global Tea Sensation CHAGEE Opened U.S. First Modern Tea House at Westfield Century City, Los Angeles
• Asset-Backed Green Crypto: Fueling the Trillion-Dollar Revolution
• OGN INVESTIGATION NOTICE: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm

Some of the institutions that have evaluated Plenty include Stanford University, Boston University, Emory University, Syracuse University, Johns Hopkins University, UCLA, Virginia Tech, Northeastern University, and Universitätsklinikum Erlangen. With such positive results from reputable sources, Plenty has the potential to revolutionize various industries and research fields such as drug discovery, cancer research, and neurodegenerative disease studies.

Plenty can be purchased directly from http://getplenty.bio at an introductory price of $200 per 500mL bottle and $50 per 60mL sample. These prices are significantly lower than those of FBS, making it an attractive option for researchers and companies alike.

Omeat's commitment to animal welfare is evident in their selection of cows that are free of zoonotic diseases and allowed to graze freely on a large pasture. This eliminates the need for environmentally destructive feedlots, making Plenty a sustainable and ethical choice.

With its proven success and ethical production process, Plenty has the potential to be a game-changer in the world of cell culture. Researchers and companies can now have access to a cost-effective and humane alternative to FBS, thanks to Omeat's innovative product.

---

Show All News | Report Violation